Meta Platforms, Inc.
META · Nasdaq · CIK 0001326801
SIC 7370
Services-Computer Programming, Data Processing, Etc.
Category
Technology
Entity
operating
Incorp.
DE
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$598.85
-10.78 (-1.77%)
Open
$604.57
High
$604.91
Low
$598.08
Prev Close
$609.63
Volume
13,248,859
52W High
$794.38
52W Low
$520.26
50-day MA
$628.24
Quote as of: 2026-05-11
Market Cap
$1.56T
P/E
22.27
P/B
6.36
PEG
0.93
EPS
27.52
BPS
85.87
Dividend Yield
0.35%
Beta
1.24
ROE
27.83%
ROA
16.52%
D/E Ratio
0.68
Current Ratio
2.60
Operating Margin
204.85%
Net Margin
148.72%
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (7 methods)
$325.86B
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $543.61B | +186% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $145.10B | +972% |
Justified P/E 순이익 × 산업 평균 P/E | $906.87B | +72% |
P/B 배수 자본 × 산업 평균 P/B | $325.86B | +377% |
P/S 배수 매출 × 산업 평균 P/S | $81.31B | +1813% |
DCF (Gordon) CF × (1+g) / (r − g) | $410.79B | +279% |
DDM (Gordon) D × (1+g) / (r − g) | $47.43B | +3180% |
▶ Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +377.4% below the current market cap → the stock trades above most formulas' estimates (overvalued). 7 methods flag overvalued, 0 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +186.2%√(22.5 × 순이익 × 자본)
Current
$1.56T
Implied fair
$543.61B
Gap (current − fair)
+$1.01T(+186.2%)
NetIncome = $60.46B Equity = $217.24B √(22.5 × $60.46B × $217.24B) = $543.61B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Overvalued +972.2%순이익 × (8.5 + 2 × 성장률%)
Current
$1.56T
Implied fair
$145.10B
Gap (current − fair)
+$1.41T(+972.2%)
NetIncome = $60.46B Growth g = -3.1% → cap -3.1% Multiple = 8.5 + 2 × -3.1 = 2.4× $60.46B × 2.4 = $145.10B
- EPS 성장률 -3.1%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 2.4x
Justified P/E
Overvalued +71.6%순이익 × 산업 평균 P/E
Current
$1.56T
Implied fair
$906.87B
Gap (current − fair)
+$648.88B(+71.6%)
NetIncome = $60.46B Industry P/E = 15× $60.46B × 15 = $906.87B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +377.4%자본 × 산업 평균 P/B
Current
$1.56T
Implied fair
$325.86B
Gap (current − fair)
+$1.23T(+377.4%)
Equity = $217.24B Industry P/B = 1.5× $217.24B × 1.5 = $325.86B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Overvalued +1813.4%매출 × 산업 평균 P/S
Current
$1.56T
Implied fair
$81.31B
Gap (current − fair)
+$1.47T(+1813.4%)
Revenue = $40.65B Industry P/S = 2× $40.65B × 2 = $81.31B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +278.7%CF × (1+g) / (r − g)
Current
$1.56T
Implied fair
$410.79B
Gap (current − fair)
+$1.14T(+278.7%)
FCF = $46.11B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $46.11B × (1 + -2.0%) / (9.0% − -2.0%) = $410.79B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 -2.0% (실질 GDP 수준)
DDM (Gordon)
Overvalued +3180.0%D × (1+g) / (r − g)
Current
$1.56T
Implied fair
$47.43B
Gap (current − fair)
+$1.51T(+3180.0%)
Dividend D = $5.32B Discount r = 9.0% Growth g = -2.0% $5.32B × (1 + -2.0%) / (9.0% − -2.0%) = $47.43B
- 배당 입력: 실제 지급 배당
- 할인율 9.0%
- 배당 영구 성장률 -2.0%
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +100.4% | +133.8% | +167.3% | +200.7% | +234.1% |
| 2% | +65.4% | +98.5% | +131.6% | +164.6% | +197.7% |
| 3% | +31.0% | +63.8% | +96.5% | +129.3% | +162.1% |
| 4% | -2.7% | +29.8% | +62.2% | +94.7% | +127.1% |
| 5% | -35.7% | -3.6% | +28.5% | +60.7% | +92.8% |
DDM sensitivity: discount rate × dividend growth
Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +1635.9% | +1925.2% | +2214.6% | +2503.9% | +2793.2% |
| 2% | +1332.4% | +1618.9% | +1905.4% | +2191.9% | +2478.4% |
| 3% | +1034.8% | +1318.5% | +1602.2% | +1885.9% | +2169.6% |
| 4% | +742.9% | +1023.9% | +1304.9% | +1585.9% | +1866.8% |
| 5% | +456.6% | +734.9% | +1013.2% | +1291.5% | +1569.8% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-01-29
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of Revenue | 36,175 | 30,161 | 25,959 | 25,249 | 22,649 |
| Operating Income | 83,276 | 69,380 | 46,751 | 28,944 | 46,753 |
| Net Income | 60,458 | 62,360 | 39,098 | 23,200 | 39,370 |
| EPS (Basic) | 23.98 | 24.61 | 15.19 | 8.63 | 13.99 |
| EPS (Diluted) | 23.49 | 23.86 | 14.87 | 8.59 | 13.77 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 366,021 | 276,054 | 229,623 | 185,727 | 165,987 |
| Current Assets | 108,722 | 100,045 | 85,365 | 59,549 | 66,666 |
| Cash & Equivalents | 35,873 | 43,889 | 41,862 | 14,681 | 16,601 |
| Total Liabilities | 148,778 | 93,417 | 76,455 | 60,014 | 41,108 |
| Current Liabilities | 41,836 | 33,596 | 31,960 | 27,026 | 21,135 |
| Long-term Debt | 58,744 | 28,826 | 18,385 | — | — |
| Total Equity | 217,243 | 182,637 | 153,168 | 125,713 | 124,879 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 115,800 | 91,328 | 71,113 | 50,475 | 57,683 |
| Investing CF | -102,003 | -47,150 | -24,495 | -28,970 | -7,570 |
| Financing CF | -20,370 | -40,781 | -19,500 | -22,136 | -50,728 |
| CapEx | 69,691 | 37,256 | 27,266 | 31,431 | 18,567 |
| Dividends Paid | 5,324 | 5,072 | — | — | — |
📄 SEC Filings
Current Report
8-K
2026-05-04
Open →
Quarterly Report
10-Q
2026-04-30
Open →
Current Report
8-K
2026-04-29
Open →
Proxy Statement
DEF 14A
2026-04-16
Open →
Current Report
8-K
2026-04-14
Open →
Annual Report
10-K
2026-01-29
Open →
Current Report
8-K
2026-01-28
Open →
Current Report
8-K
2026-01-16
Open →
Other filings (92)
Insider Transaction
FORM 4
2026-05-11
Open →
144
xsl144X01/primary_doc.xml
2026-05-11
Open →
PX14A6G
o511264px14a6g.htm
2026-05-11
Open →
Insider Transaction
FORM 4
2026-05-06
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
144
xsl144X01/primary_doc.xml
2026-05-04
Open →
424B2
424B2
2026-05-01
Open →
144
xsl144X01/primary_doc.xml
2026-05-01
Open →
FWP
FWP
2026-04-30
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
424B2
424B2
2026-04-30
Open →
S-3ASR
S-3ASR
2026-04-30
Open →
Insider Transaction
FORM 4
2026-04-29
Open →
PX14A6G
px14a6g14098003_04282026.htm
2026-04-28
Open →
144
xsl144X01/primary_doc.xml
2026-04-27
Open →
PX14A6G
z424260px14a6g.htm
2026-04-27
Open →
Insider Transaction
FORM 4
2026-04-22
Open →
PX14A6G
o421260px14a6g.htm
2026-04-21
Open →
144
xsl144X01/primary_doc.xml
2026-04-20
Open →
Insider Transaction
FORM 4
2026-04-17
Open →
ARS
ARS
2026-04-16
Open →
DEFA14A
DEFA14A
2026-04-16
Open →
Insider Transaction
FORM 4
2026-04-15
Open →
144
xsl144X01/primary_doc.xml
2026-04-15
Open →
144
xsl144X01/primary_doc.xml
2026-04-13
Open →
PX14A6G
o330262px14a6g.htm
2026-03-30
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
Insider Transaction
FORM 4
2026-03-25
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
144
xsl144X01/primary_doc.xml
2026-03-23
Open →
Insider Transaction
FORM 4
2026-03-18
Open →
Insider Transaction
FORM 4
2026-03-18
Open →
144
xsl144X01/primary_doc.xml
2026-03-16
Open →
144
xsl144X01/primary_doc.xml
2026-03-16
Open →
Insider Transaction
FORM 4
2026-03-11
Open →
144
xsl144X01/primary_doc.xml
2026-03-09
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
144
xsl144X01/primary_doc.xml
2026-03-02
Open →
Insider Transaction
FORM 4
2026-02-27
Open →
144
xsl144X01/primary_doc.xml
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
Insider Transaction
FORM 4
2026-02-24
Open →
144
xsl144X01/primary_doc.xml
2026-02-24
Open →
144
xsl144X01/primary_doc.xml
2026-02-23
Open →
Insider Transaction
FORM 4
2026-02-20
Open →
Insider Transaction
FORM 4
2026-02-20
Open →
Insider Transaction
FORM 4
2026-02-20
Open →
144
xsl144X01/primary_doc.xml
2026-02-20
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
144
xsl144X01/primary_doc.xml
2026-02-18
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-11
Open →
144
xsl144X01/primary_doc.xml
2026-02-10
Open →
144
xsl144X01/primary_doc.xml
2026-02-09
Open →
Insider Transaction
FORM 4
2026-02-04
Open →
144
xsl144X01/primary_doc.xml
2026-02-03
Open →
144
xsl144X01/primary_doc.xml
2026-02-02
Open →
S-8
S-8
2026-01-29
Open →
Insider Transaction
FORM 4
2026-01-28
Open →
144
xsl144X01/primary_doc.xml
2026-01-27
Open →
144
xsl144X01/primary_doc.xml
2026-01-26
Open →
3
FORM 3
2026-01-22
Open →
Insider Transaction
FORM 4
2026-01-22
Open →
3
FORM 3
2026-01-20
Open →
Insider Transaction
FORM 4
2026-01-20
Open →
144
xsl144X01/primary_doc.xml
2026-01-20
Open →
144
xsl144X01/primary_doc.xml
2026-01-20
Open →
144
xsl144X01/primary_doc.xml
2026-01-15
Open →
Insider Transaction
FORM 4
2026-01-14
Open →